Splenic red pulp macrophages (RPM) degrade senescent erythrocytes and recycle heme-associated iron. The transcription factor SPI-C is selectively expressed by RPM and is required for their development, but the physiologic stimulus inducing Spic is unknown. Here, we report that Spic also regulated the development of F4/80 + VCAM1 + bone marrow macrophages (BMM) and that Spic expression in BMM and RPM development was induced by heme, a metabolite of erythrocyte degradation. Pathologic hemolysis induced loss of RPM and BMM due to excess heme but induced Spic in monocytes to generate new RPM and BMM. Spic expression in monocytes was constitutively inhibited by the transcriptional repressor BACH1. Heme induced proteasome-dependent BACH1 degradation and rapid Spic derepression. Furthermore, cysteine-proline dipeptide motifs in BACH1 that mediate hemedependent degradation were necessary for Spic induction by heme. These findings are the first example of metabolite-driven differentiation of a tissue-resident macrophage subset and provide new insights into iron homeostasis.
INTRODUCTION
Macrophage function extends beyond immunity to include roles in embryonic development, wound repair, and local tissue homeostasis (Pollard, 2009; Murray and Wynn, 2011) . Macrophages in various tissues have distinct tissue-specific homeostatic roles, such as osteoclasts that regulate bone morphogenesis, alveolar macrophages that regulate pulmonary surfactant turnover, and splenic red pulp macrophages (RPM) that regulate erythrocyte degradation and iron recycling (Pollard, 2009; Gordon and Taylor, 2005; Taylor et al., 2005; Murray and Wynn, 2011; Marks and Lane, 1976; Cecchini et al., 1994; Shibata et al., 2001; Dranoff et al., 1994; Kohyama et al., 2009 ). These tissue-resident macrophages are thought to be maintained by the differentiation of circulating monocytes and local proliferation (Landsman and Jung, 2007; Jenkins et al., 2011; Hume, 2008) . Recently, a subset of tissue-resident macrophages have been shown to arise from cells in the primitive ectoderm of the yolk sac without a monocytic intermediate (Schulz et al., 2012a) . However, factors controlling the relative contribution of yolksac-derived and monocyte-derived macrophages are unknown.
RPM, and to some extent bone marrow macrophages (BMM) and liver macrophages, phagocytose senescent or damaged erythrocytes to degrade heme and release the heme-associated iron (Ganz, 2012; Beaumont and Delaby, 2009) . Iron is an essential element required for many critical biological processes (Pantopoulos et al., 2012) . The majority of iron in the body is contained within the heme moiety of hemoglobin inside erythrocytes, and each day about 3.6 3 10 11 erythrocytes are recycled by the macrophage-dependent pathway, supplying the vast majority of the daily iron requirement (Andrews and Schmidt, 2007; Ganz, 2012; Pantopoulos et al., 2012; Bratosin et al., 1998) . Given the proficiency of RPM and BMM in erythrophagocytosis, these cells experience significant increases in intracellular heme following erythrocyte damage in pathological conditions such as autoimmune hemolytic anemia, drug-or toxin-induced hemolysis, and sickle cell disease (Guillaud et al., 2012) . However, very high levels of intracellular heme are toxic to these cells as demonstrated by the elimination of RPM and BMM upon inactivation of the heme-degrading enzyme heme oxygenase 1 (HO1) (Kovtunovych et al., 2010) . Indeed, excess intracellular heme is toxic to macrophages even with intact Ho1 (Cambos and Scorza, 2011) . Therefore, conditions leading to increased heme levels may require ''replenishment'' of the RPM and BMM population to maintain iron homeostasis. We have previously reported the requirement of the transcription factor SPI-C for the development of RPM (Kohyama et al., 2009) . To examine the signals controlling Spic induction and RPM development in vivo, we targeted enhanced green fluorescent protein (EGFP) for expression under the control of the native Spic locus. Our analysis demonstrated that it is the heme moiety derived from senescent or damaged erythrocytes that is the physiologic trigger for inducing Spic. This induction appeared to take place in a subset of monocytes and proceeds by the heme-mediated degradation of BACH1 protein, a transcriptional repressor that inhibited Spic under normal conditions. We found that Spic also regulated BMM that phenotypically resembled RPM, and that the heme-BACH1-Spic circuit induced compensatory development of RPM and BMM during pathological hemolysis. These findings uncover a novel metabolite-driven pathway regulating tissue-specific macrophage development and provide insights into iron homeostasis.
RESULTS

Spic Is Required for the Development of F4/80
hi Macrophages in the Spleen and Bone Marrow Spic encodes a member of the Spi subfamily of ETS transcription factors and is required for the development of RPM (Bemark et al., 1999; Carlsson et al., 2002; Kohyama et al., 2009 Figure S1D ).
As expected, EGFP levels were high in RPM ( Figures 1A and  1B) . We also observed high levels of EGFP in F4/80 hi cells in the bone marrow (BM) (Figures 1A and 1B) and in a small fraction of F4/80 hi cells in the liver, but not in other locations ( Figure S2A ).
Spic-EGFP
hi cells in the BM expressed low levels of the myeloid marker CD11b but were neither neutrophils (Ly6G hi ) nor monocytes (Ly6C hi ) ( Figure 1C ). However, these Spic-EGFP hi BM cells expressed high levels of macrophage-associated markers including F4/80, VCAM1, CD68, and CD169, supporting their identity as BMM ( Figure 1C ). Furthermore, Spic-EGFP hi BMM displayed a striking similarity to RPM (Kohyama et al., 2009; Hemmi et al., 2009) Figures S2B-S2E ). BMM and RPM were negative for the dendritic cell-specific marker Zbtb46 (Satpathy et al., 2012) and dendritic cells did not express Spic-EGFP ( Figure S2F ). These results demonstrated that Spic is expressed at high levels in both BMM and RPM, suggesting a common developmental origin for these macrophage subsets. Indeed, Spic À/À mice were found to be deficient in F4/80 hi VCAM1
hi BMM in addition to the previously reported loss of RPM ( Figure 1D ). Macrophages in other locations surveyed were present in normal numbers ( Figure S2G ). (Figures 1C) , which is similar to the reported surface marker profile of the previously described CD169 + BMM (Chow et al., 2011; Chow et al., 2013) . CD169 expression was significantly decreased in Spic À/À BM, indicating loss of these macrophages ( Figure 1E ). CD169 + BMM have been suggested to support normal erythropoiesis in the BM . Proerythroblast frequencies were reduced in the BM of Spic À/À mice, which is consistent with the reported phenotype upon ablating CD169 + BMM ( Figure 1F ). Furthermore, hemoglobin recovery from hemolytic anemia appeared impaired, albeit not statistically significantly, in Spic À/À mice ( Figure S2H ). Figure S3A ). Agonist-mediated activation of the nuclear receptors NR1D1, PPARg, LXRa, and RXRa (Heng and Painter, 2008) , which are each highly expressed in RPM, also failed to induce Spic-EGFP ( Figures S3B-S3D Figures  2A, 2B , and S4A). Heme-induced Spic expression was confirmed by reverse transcription PCR and was dose-dependent ( Figure 2C ).
The enzyme HO1 converts heme to biliverdin, releasing the heme-associated iron, while the enzyme biliverdin reductase (BLVR) converts biliverdin to bilirubin (Beaumont and Delaby, 2009 ). Thus, heme-induced Spic expression could be mediated by heme itself or by one of these heme metabolites. Bilirubin and biliverdin failed to induce Spic-EGFP in Spic igfp/igfp BMDM ( Figure 2D ). Furthermore, iron chelation by deferoxamine or HO1 inhibition by chromium mesoporphyrin (Crmp) (Schulz et al., 2012b) failed to inhibit heme-mediated Spic-EGFP induction ( Figures S4B and S4C ). These results argue against a role for heme metabolites in Spic induction. We further confirmed this interpretation by genetic analysis. Ho1 À/À mice were obtained (Poss and Tonegawa, 1997a) Figure 2E ). Notably, BMDM were increasingly sensitive to heme-mediated Spic induction with loss of each allele of Ho1 ( Figure 2E ). These results further demonstrate a direct role for heme in Spic induction.
Heme Induces Spic Expression in a Subset of Myeloid Cells In Vivo Ho1 À/À mice have been previously reported to lack RPM and BMM (Kovtunovych et al., 2010 Figure 3B ). Additionally, induction of intravascular hemolysis by phenylhydrazine (PDZ) (Itano et al., 1975; Chow et al., 2013) were located in the red pulp area, similar to RPM ( Figure 3D ). These findings suggest a role of heme in the generation of CD11b hi Spic-EGFP lo cells in vivo.
Loss of RPM in Ho1
À/À mice is thought to result from hemeinduced toxicity (Kovtunovych et al., 2010; Poss and Tonegawa, 1997b) . Consistent with this, higher levels of heme induced the loss of Ho1 Figure 3E ). Cell death was induced within 24 hr of exposure to high levels of heme in Ho1 À/À BMDM, demonstrating the increased sensitivity of Ho1 À/À macrophages to heme-induced toxicity ( Figure 3F ).
Phagocytosis of senescent erythrocytes is the major source of heme in RPM and mouse erythrocytes have a lifespan of about 40 days (Van Putten, 1958) . Notably, while RPM and BMM were absent in older (R2 months) Ho1 À/À Spic igfp/igfp mice, they were present in younger (4-5 weeks) mice, further supporting that the loss of RPM in Ho1 À/À mice is secondary to hemeinduced toxicity ( Figure S5C ). (legend continued on next page) an independent approach. BM chimeras were generated with congenically marked donor cells. Consistent with previous reports , we observed significant persistent host contribution to the RPM pool after BM transplantation ( Figure 4D ). However, all pre-RPM (CD11b hi F4/80 + ) at the steady state and upon induction by Crmp were exclusively of donor origin ( Figure 4D ). This demonstrated that heme-induced pre-RPM are not a result of an acute loss of F4/80 and induction of CD11b on RPM, but rather are derived de novo from adult hematopoietic stem cells. We next asked whether, and under what conditions, monocytes give rise to pre-RPM and RPM in vivo. Donor monocytes, like unfractionated BM cells, generated pre-RPM and RPM-like cells in the presence of hemolysis in the recipient host ( Figures  4E and S6A ). Donor monocytes were recovered from the recipient spleen with or without hemolysis, demonstrating an equivalent ingress of the transferred monocytes ( Figure S6A) Figure 4F ). Indeed, of all genes that differ in expression by more than 20-fold between monocytes and RPM, 94% were expressed at intermediate levels in pre-RPM ( Figure S7A) Figure S7B ). To examine this phenomenon further, we generated congenically marked BM chimeras. In the absence of hemolysis, a substantial fraction of RPM were of host origin, consistent with their radio resistant property. Remarkably, hemolysis induced a complete ''takeover'' of the RPM pool by donorderived cells ( Figure 4H ). Collectively, these results strongly suggest that heme-induced pre-RPM generate RPM in the spleen.
BACH1 Is a Transcriptional Repressor of Spic
To identify the molecular basis for heme-induced Spic expression, we used gene expression microarrays to compare BMDM transcriptional profiles at various times after treatment with heme ( Figures 5A and 5B) . Heme induced the expression of Ho1 and Blvrb as well as Slc40a1, which encodes the mammalian iron exporter ( Figure 5A ), in agreement with previous reports (Delaby et al., 2008) . In addition, Spic was induced as expected, as was Treml4, which can be used as a marker for RPM ( Figure 5A ). Spic was one of the most highly induced genes, and was the only transcription factor the expression of which was substantially altered (R4-fold) by heme. This suggests that Spic expression may be induced by a heme-regulated posttranscriptional mechanism. Notably, some heme-induced genes such as Ho1, Gclm, Me1, and Slc7a11 were targets of the transcriptional repressor BTB and CNC homology 1 (BACH1) ( Figures 5A and 5B) (Warnatz et al., 2011) . BACH1 and the related factor BACH2 contain a BTB protein-protein interaction motif that mediates transcriptional repression and a basic leucine zipper (bZIP) domain that mediates heterodimerization with other bZIP transcription factors (Oyake et al., 1996) . While BACH1 target genes were induced following heme treatment, Bach1 expression was unchanged ( Figure 5B ). Compared to Bach1, Bach2 expression in BMM and RPM was very low ( Figure 5B ). Heme is known to inhibit BACH1 repressive activity (Ogawa et al., 2001) , and heme-mediated induction of Spic-EGFP + BMDM was significantly reduced with Bach1 overexpression, suggesting that BACH1 may inhibit Spic expression ( Figure 5C ). Next, we examined Bach1 À/À BMDM. While Bach1 +/+ BMDM expressed Spic only after heme treatment, Bach1 À/À BMDM showed constitutive expression of Spic ( Figure 5D ). These results demonstrate that BACH1 is a transcriptional repressor of Spic that is inhibited by heme.
Heme-Mediated Degradation of BACH1 Induces Spic Expression Bach1 transcription was not altered by heme, suggesting posttranscriptional regulation of its activity by heme. The microRNA miR-155 has been shown to target Bach1 (Yin et al., 2008) . Therefore, we next asked if heme-mediated Spic induction occurs via miR-155. RPM frequencies at steady state and RPM recovery after hemolysis were normal in Mir155 À/À mice ( Figures   6A and 6B) . Importantly, heme induced robust Spic expression in Mir155 À/À BMDM ( Figure 6C ). These results rule out a significant role of miR-155 in heme-mediated Spic induction. Heme has been suggested to induce polyubiquitination and proteasome-dependent degradation of BACH1 (Zenke- Kawasaki et al., 2007; Tan et al., 2013) . Consistent with this, we observed reductions in BACH1 protein levels with increasing heme in BMDM ( Figure 6D) . Notably, the disappearance of BACH1 protein coincided with the appearance of a higher molecular weight band on western blot, suggesting posttranslational modifications, most likely polyubiquitination ( Figure 6D ). Furthermore, heme-mediated induction of Spic-EGFP + BMDM was blocked by the proteasome inhibitor MG132, supporting a role for ubiquitination and proteasome-based degradation of BACH1 in Spic induction by heme ( Figure 6E ). BACH1 contains six heme-interacting cysteine-proline (CP) dipeptide motifs ( Figure 6F, top) (Ogawa et al., 2001 ). The four carboxy-terminal CP motifs are thought to be particularly important for heme-BACH1 interaction (Zenke-Kawasaki et al., 2007) and thus we mutated these four CP motifs to alanine-proline (AP) in order to disrupt heme binding ( Figure 6F, top) . As expected, the mutant BACH1 protein was resistant to hememediated degradation ( Figure 6F, bottom) . Notably, while overexpression of wild-type (WT) BACH1 protein reduced the expression of Spic-EGFP, mutant BACH1 completely blocked heme-induced Spic-EGFP expression in BMDM ( Figure 6G ). These results demonstrate the requirement for heme-BACH1 interactions via CP motifs for heme-mediated Spic expression.
BACH1 has been shown to heterodimerize with MAFK to suppress Ho1 expression (Sun et al., 2002; Sun et al., 2004) . In the absence of BACH1, MAFK heterodimerizes with the transcription activator NRF2 to activate Ho1 expression (Sun et al., 2002; Sun et al., 2004) . However, RPM frequency and Spic expression were normal in Spic igf/igfp Nrf2 À/À mice, suggesting that while Spic and Ho1 are both repressed by BACH1, they rely on distinct activating factors ( Figure 6H ). Taken together, these results demonstrate that heme-mediated induction of Spic proceeds via proteasome-dependent degradation of the transcriptional repressor BACH1 independently of NRF2.
Heme-Induced BACH1 Inhibition Promotes RPM and BMM Development In Vivo RPM and BMM were present at normal frequencies in Bach1 À/À mice ( Figure 7A ). To test for an in vivo role of Bach1 in the development of RPM and BMM, we evaluated WT and Bach1 À/À BM cells in an in vivo competitive setting. Bach1 À/À BM was significantly more efficient than WT in generating RPM and BMM (Figures 7B). This effect was specific to these lineages, since Bach1 À/À BM was equal to WT in generating macrophages at other locations and in generating other myeloid cells ( Figures  7B and 7C ). Since the competitive advantage of Bach1 À/À BM in the generation of macrophages was evident only at sites of active erythrophagocytosis, RPM development may involve an additional step that is heme-dependent but Bach1-independent. Thus, we compared gene expression in Bach1 À/À and WT BMDM in the presence or absence of heme ( Figure 7D ). As controls, we found that derepression of Spic, Ho1, and Slc40a1 by heme was dependent on Bach1 ( Figure 7D) . Notably, few genes were heme-induced but Bach1-independent; one such gene was the RPM-associated marker Treml4 ( Figures  7D and 7E) . Therefore, BACH1 inhibition at sites of erythrophagocytosis controls RPM and BMM development through derepression of Spic. In summary, we identified the first environmental trigger inducing development of a defined tissue-specific macrophage subset. We showed that BACH1 was a transcriptional repressor of Spic and that heme-induced proteasome-dependent degradation of BACH1 protein in monocytes led to Spic expression and promoted RPM and BMM development ( Figure 7F) . Furthermore, we showed that this pathway was important in maintaining RPM and BMM homeostasis during pathological hemolysis.
DISCUSSION
RPM actively accrue heme via erythrophagocytosis, CD163 receptor-mediated uptake of circulating hemoglobin-haptoglobin complexes, and CD91 receptor-mediated uptake of circulating heme-hemopexin complexes (Hvidberg et al., 2005; Kristiansen et al., 2001; Bratosin et al., 1998) . Hemolysis and erythrocyte damage lead to an acute buildup of heme in these cells, resulting in heme-induced toxicity. Such pathological conditions therefore have a ''double impact'' on the macrophage-based iron recycling machinery: they acutely increase the quantity of heme that must be degraded, while excess heme is toxic to the same macrophages that degrade this substrate. Therefore, the induction of Spic and the development of pre-RPM upon increased environmental heme represent an important adaptive response during pathologic hemolysis.
Recent studies have questioned the monocyte origin of macrophages, instead suggesting that most tissue-resident macrophages are maintained by local proliferation (Schulz et al., 2012a; Hashimoto et al., 2013) . Although this may be true at steady state, our findings support a critical role for monocytes in maintaining RPM and BMM homeostasis during pathological hemolysis. Similarly, monocytes may also be critical in maintaining other tissue-resident macrophages in response to tissuespecific insults. This suggests a dichotomy in the developmental mechanisms that maintain tissue-resident macrophages at steady state and under pathological conditions. Both BMM and RPM have been implicated in heme degradation and iron recycling. Our finding that these tissue-resident macrophage subsets share similar developmental pathways underscores the importance of function, rather than location, in the classification of tissue-resident macrophages. Notably, high levels of HO1 expression, similar to those in RPM, have been observed in macrophages located in human atherosclerotic plaques (Boyle et al., 2009) . Therefore, macrophages that are functionally equivalent to Spic-dependent BMM and RPM may develop at other locations with increased environmental heme, such as hematomas and atherosclerotic plaques. In this regard, the expression of Spic in a small subset of liver macrophages is intriguing. Liver macrophages are also known to engulf damaged erythrocytes (Beaumont and Delaby, 2009 ). Therefore, Spic-EGFP + macrophages in the liver likely represent cells that actively phagocytose erythrocytes. BACH1 degradation by heme allows its binding partner MAFK to heterodimerize with NRF2 to induce Ho1 expression (Sun et al., 2002; Sun et al., 2004) . However, Spic induction was not dependent on NRF2. Furthermore, bioinformatic analysis of the Spic locus did not reveal the presence of any classic MARE sequences recognized by MAF. These findings suggest that Spic regulation by BACH1 may be independent of MAFK, and that BACH1 may suppress Spic as a homodimer or as a heterodimer with an unknown partner.
In summary, our findings provide insights into iron homeostasis by linking the development of iron-recycling macrophages in the spleen and BM to a molecular substrate of their metabolic function. This developmental pathway may be a paradigm for the role of tissue-specific metabolites in the maintenance of tissue-resident macrophages. Wang at the University of Utah. Mice were bred and maintained in our specific pathogen-free animal facility according to institutional guidelines.
Histology
Histology was performed on fixed and frozen 6-8 mm sections following established protocols as described in the Supplemental Information.
Cell Preparation BM and peritoneal cells were harvested with Iscove's modified Dulbecco's medium (IMDM) with 10% FCS. Cells from the various organs were harvested by digesting with enzymes in IMDM following established protocols as described in the Supplemental Information.
Flow Cytometry and Cell Sorting
Flow cytometry was performed on a FACS Canto (BD Biosciences) and cell sorting performed on a FACS Aria II (BD Biosciences) using established protocols as described in the Supplemental Information. All flow cytometry data were analyzed with FlowJo software (Tree Star).
Transplantation Assay
For BM chimeras, recipient mice were lethally irradiated with two staggered doses of 550 rad several hours apart and transplanted by tail vein injection with BM cells obtained from donor mice.
Monocyte Transfers
Monocytes were purified by MACS-based depletion and enrichment as described in the figure legends. For transfer of Spic-EGFP + and Spic-EGFP À monocytes, the MACS-purified monocytes were further subjected to cell sorting. All recipient mice were treated with PDZ or PBS and some recipient mice additionally received sublethal radiation with a single dose of 550 rad as described in figure legends.
In Vitro Cultures BM cells were collected as described above and cultured in IMDM + 10% FCS supplemented with 20 ng/ml of GM-CSF (315-03, PeproTech), M-CSF (315-02, PeproTech), or G-CSF (300-23, PeproTech) as indicated. Unless otherwise specified, BMDM indicates the adherent BM-derived macrophages generated in the presence of 20 ng/ml GM-CSF. Cells were plated at 2 3 10 5 /ml for GM-CSF cultures and 0.5 3 10 6 /ml for M-CSF and G-CSF cultures.
Microarray Analysis
Gene expression analyses were carried out using Affymetrix platforms and standard protocols as described in the Supplemental Information. All data have been deposited at GEO (GSE46983, GSE46984, and GSE53796). 
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